Clinical Trials Browser

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT01507506 2026-04-14

SPECTRO GLIO

Phase 3 Terminated

180 enrolled

CNS

Glioblastoma

NCT06419946 2026-04-13

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Phase 3 Recruiting

200 enrolled

CNS

Glioblastoma

NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Phase 3 Recruiting

32 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT05095376 2026-04-03

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Phase 3 Active not recruiting

265 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT06388733 2026-04-01

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

Phase 3 Recruiting

450 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT03663725 2026-03-30

StrateGlio

Phase 3 Active not recruiting

486 enrolled

CNS

Glioblastoma

NCT06556563 2026-03-13

EF-41

Phase 3 Recruiting

741 enrolled

CNS

Glioblastoma

NCT07461948 2026-03-10

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Phase 3 Recruiting

15 enrolled

CNS

Glioblastoma

NCT05303519 2026-03-05

SIGMA

Phase 3 Recruiting

365 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT07452458 2026-03-05

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Phase 3 Not yet recruiting

398 enrolled

CNS

Glioblastoma

NCT07195591 2026-03-04

BRIDGES

Phase 3 Recruiting

766 enrolled

CNS

Glioblastoma, Neoplasms

NCT06448286 2026-02-19

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Phase 3 Not yet recruiting

60 enrolled

CNS

Glioblastoma

NCT05904119 2026-02-17

LEGATO

Phase 3 Recruiting

411 enrolled

CNS

Glioblastoma

NCT07376304 2026-01-29

BrainUS-AI

Phase 3 Not yet recruiting

100 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma

Clinical Trials

IPAX BrIGHT

SPECTRO GLIO

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

StrateGlio

EF-41

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

SIGMA

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

BRIDGES

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

LEGATO

BrainUS-AI